GO
Loading...

Drug Retail

More

  • Sept 30- U.S. drugstore chain operator Walgreen Co reported a 6.2 percent rise in quarterly sales, helped by higher prescription sales, sending its shares up more than 3 percent in premarket trading.

  • Problems for potpreneurs     Wednesday, 24 Sep 2014 | 1:54 PM ET

    CNBC's Kate Rogers reports on the uphill battle facing potpreneurs.

  • Tekmira soars on FDA news     Monday, 22 Sep 2014 | 2:05 PM ET

    Tekmira said regulators in the U.S. and Canada authorized use of its experimental drug for Ebola through an expanded access program. CNBC's Meg Tirrell provides insight.

  • High at work     Thursday, 18 Sep 2014 | 1:54 PM ET

    A new survey from Mashable finds nearly 10 percent of Americans admit to smoking pot before heading into the office. CNBC's Kate Rogers shares the difficulties in testing employees.

  • Sept 18- Rite Aid Corp cut its full-year profit forecast for the second time in about three months due to lower margins in its pharmacy business, sending its shares down more than 16 percent.

  • Sept 18- Rite Aid Corp, the third-largest U.S. drugstore chain, cut its full-year profit forecast for the second time, citing lower margins in its pharmacy business, sending its shares down 11 percent in premarket trading.

  • Rite Aid beats Street 2Q forecasts Thursday, 18 Sep 2014 | 8:28 AM ET

    CAMP HILL, Pa.— Rite Aid Corp. topped analyst expectations for its second quarter, but the drugstore chain's stock tumbled Thursday after it also dropped its fiscal 2015 earnings forecast for the second straight quarter due in part to an expected decrease in pharmacy profitability.

  • Rite Aid cuts full-year profit forecast for second time Thursday, 18 Sep 2014 | 7:27 AM ET

    Sept 18- Rite Aid Corp, the third largest U.S. drugstore chain, cut its full-year profit forecast for the second time this year as lower margins from its pharmacy business continue to eat into earnings. Rite Aid shares fell nearly 9 percent in premarket trading on Thursday after the company also shaved the top end of its sales forecast.

  • Avanir up on Alzheimer's trial     Monday, 15 Sep 2014 | 1:03 PM ET

    Avanir Pharma is up more than 60 percent, after the company said its drug was more effective in reducing agitation associated with Alzheimer's, compared with a placebo. CNBC's Meg Tirrell speaks to the company's CEO Keith Katkin.

  • Orexigen's obesity pill     Thursday, 11 Sep 2014 | 1:11 PM ET

    Orexigen's obesity pill is called Contrave, and it's been approved in the U.S. CNBC's Meg Tirrell reports.

  • Food prices hit 4-year low, Russia ban hurts Thursday, 11 Sep 2014 | 8:20 AM ET

    The UN food price index has dipped to a four-year low as good weather has resulted in an oversupply of cereals and dairy imports have slowed.

  • Walgreen adds activist hedge fund founder to board Monday, 8 Sep 2014 | 7:57 AM ET
    Barry Rosenstein, founder and managing partner of Jana Partners

    Walgreen is naming Jana founder Rosenstein to its board and the activist investor will get a say in choosing at least one additional director.

  • BISMARCK, N.D., Sept 4- North Dakota's oil boom has fueled a construction bonanza for new supermarkets, restaurants and clothing stores. But try finding a Rite Aid, Walgreens or other national pharmacy chain in the state, the fastest-growing economy in the nation, and you'll be largely out of luck.

  • Aug 22- Pharmacy chain Walgreen Co suffered a system outage for several hours on Friday, taking all of its 8,200 pharmacy outlets offline and delaying prescription orders. The company faced a "technical issue" during a system update and had to bring the entire system offline to resolve it, spokesman Michael Polzin said.

  • Walgreen stores go offline due to technical glitch Friday, 22 Aug 2014 | 5:21 PM ET

    Aug 22- Pharmacy chain Walgreen Co suffered a system outage for several hours on Friday, taking all of its 8,200 pharmacy outlets offline and delaying prescription orders. The company faced a "technical issue" during a system update and had to bring the entire system offline to resolve it, spokesman Michael Polzin said.

  • Big change for pain drugs     Friday, 22 Aug 2014 | 2:12 PM ET

    CNBC's Meg Tirrell reports the Drug Enforcement Administration is changing the rules around pain drugs like Vicodin. The drugs will be deemed "schedule 2 substances," versus the less restrictive "schedule 3."

  • Obesity treatment sales fall short     Monday, 18 Aug 2014 | 6:26 AM ET

    CNBC's Meg Tirrell provides insight to the definition of obesity by the CDC, and which drug companies are working on treatments in the space.

  • Aug 14- Top U.S. hedge fund managers did some shopping for shares of discount retailer Dollar General Corp and drug store operator Walgreen Co in the second quarter.

  • Forest fire threatens illegal marijuana grows     Thursday, 14 Aug 2014 | 1:29 PM ET

    A massive fire in Northern California has so far burned close to 12,000 acres and injured 12 people. CNBC's Jane Wells reports on the costs to the state, as well as to marijuana growers.

  • Ebola not easily spread: Doctor     Thursday, 7 Aug 2014 | 3:19 PM ET

    Dr. Beth Bell, CDC Infectious Diseases Center, discusses the Ebola crisis in West Africa, and the risks to U.S. citizens. Bell explains current experimental treatments.